About ALSF

New cancer target, let-7, unifies theories on neuroblastoma’s origins

 » View all news titles
 » View titles this week
» View titles this month

Vector

07/12/2016

Striking the nerve tissue, neuroblastoma is the most common cancer in infants and toddlers. Great strides have been made in its treatment, but advanced cases still are often fatal, and children who survive often face life-long physical and intellectual challenges related to their treatment. 

A study published online by Nature last week, led by researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, finds that a microRNA called let-7 is central in curbing neuroblastoma. The study unifies several theories about neuroblastoma and could bring focus to efforts to find a targeted, nontoxic alternative to chemotherapy. 

>>Read more